Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial

Benzer Materyaller

• Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial
  Yazar:: Fichtenbaum, Carl J, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Rationale and Design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) RCT# NCT02344290
  Yazar:: Grinspoon, Steven K., ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum
  Yazar:: Smeaton, Laura M, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers
  Yazar:: Hoffmann, Udo, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: Critical role of central coordination
  Yazar:: Fitch, Kathleen V., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)